Last reviewed · How we verify

NCT06297278: BRAINS

Exercise Facilitation of Adolescent Fear Extinction, Frontolimbic Circuitry, and Endocannabinoids

Recruiting now NA Last updated 7 August 2025
What this trial tests

NA trial testing Moderate Intensity Exercise in Adolescence in 174 participants. Currently enrolling.

Timeline
17 May 2024
Primary endpoint
30 April 2028
30 April 2028

Quick facts

Lead sponsorWayne State University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment174
Start date17 May 2024
Primary completion30 April 2028
Estimated completion30 April 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Wayne State University

Who can join

Adults 14 to 17, any sex, with Adolescence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anxiety disorders commonly begin during adolescence, and are characterized by deficits in the ability to inhibit or extinguish pathological fear. Recent research has provided new understanding of how fear is learned and can be regulated in the adolescent brain, and how the endocannabinoid system shapes these processes; however, these advances have not yet translated into improved therapeutic outcomes for adolescents with anxiety. This study will test whether a behavioral intervention, acute exercise, can help to improve fear regulation by enhancing brain activity and endocannabinoid signaling. This line of research may ultimately lead to more effect treatments for adolescent anxiety, and to new preventive strategies for at-risk youth.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Moderate Intensity Exercise

Trials testing the same drug.

Other recruiting trials for Adolescence

Currently open trials in the same condition.

Other Wayne State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06297278.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing